Back to Search
Start Over
Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians.
- Source :
-
Annals of internal medicine [Ann Intern Med] 2020 Dec 15; Vol. 173 (12), pp. 1002-1003. Date of Electronic Publication: 2020 Sep 15. - Publication Year :
- 2020
-
Abstract
- The prescription drug market in the United States relies on competition to keep prices reasonable. Although many policies have been implemented to spur competition and decrease costs for patients, these policies may be outdated and should be redesigned and updated to achieve success in the current prescription drug market. In this paper, the American College of Physicians (ACP) proposes that new policies should be implemented to prevent market manipulation, help lower-cost alternatives make it to the market faster, and ensure a robust and competitive market for generic and biosimilar drugs. The ACP believes these changes will have a meaningful effect on patients without shifting costs to other areas of the health care system.
- Subjects :
- Biosimilar Pharmaceuticals economics
Biosimilar Pharmaceuticals therapeutic use
Drug Industry economics
Humans
Organizational Policy
Orphan Drug Production economics
Orphan Drug Production legislation & jurisprudence
Prescription Drugs therapeutic use
Societies, Medical
United States
Economic Competition
Health Policy economics
Prescription Drugs economics
Subjects
Details
- Language :
- English
- ISSN :
- 1539-3704
- Volume :
- 173
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Annals of internal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 32926798
- Full Text :
- https://doi.org/10.7326/M19-3773